Chordia Therapeutics Inc.
|
Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
190A |
Pharmaceuticals |
Growth |
SBI SECURITIES Co.,Ltd. |
2024/05/10 |
2024/06/14 |
【Description】 |
|
IPO Information |
Opening Price |
Y255 |
Total Amount |
Y1,601,145,000 |
IPO Price |
Y153 |
--Company |
Y1,280,916,000 |
Aggregate Value (based on Initial Price) |
16,714 (Unit:1 million) |
--Leading Shareholder |
Y192,137,400 |
Listed Shares(total) |
10,465,000 |
--Lead Manager |
Y128,091,600 |
Trading Unit |
100 |
|
Offering Price PER (based on previous period) |
38.64 |
Offering Price PBR (based on previous period) |
1.93 |
公開価格PER(今期予想ベース) |
-3.79 |
Initial Price PER |
64.39 |
Initial Price PBR |
3.22 |
New Shares |
9,100,000 |
Existing Shares |
1,365,000(only O.A.) |
Shares Outstanding |
Pre IPO |
56,443,800.00 |
PostIPO |
65,543,800.00 |
Paid Up Capital |
PreIPO |
Y90,000,000 |
PostIPO |
Y659,205,288 |
Use of Funds Raised |
|
Financial Data |
Units:Y1,000 |
Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
2021/08 |
Consolidated |
- |
- |
- |
- |
Non-consolidated |
800,000 |
-525,207 |
-527,107 |
2,056,435 |
2022/08 |
Consolidated |
- |
- |
- |
- |
Non-consolidated |
|
-1,776,640 |
-1,779,060 |
4,277,539 |
2023/08 |
Consolidated |
- |
- |
- |
- |
Non-consolidated |
2,500,000 |
225,761 |
223,341 |
4,500,881 |
Interim Results
2024/02 |
Consolidated |
- |
- |
- |
- |
Non-consolidated |
|
-801,401 |
-802,611 |
3,698,270 |
Results Forecast
2024/08 |
Consolidated |
- |
- |
- |
- |
Non-consolidated |
|
-2,278,000 |
-2,280,000 |
- |
Per Share |
Units:Y1 |
Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
2021/08 |
Consolidated |
0.00 |
- |
- |
|
Non-consolidated |
-15.08 |
-58.19 |
|
2022/08 |
Consolidated |
0.00 |
- |
- |
|
Non-consolidated |
-39.78 |
-72.35 |
|
2023/08 |
Consolidated |
0.00 |
- |
- |
|
Non-consolidated |
3.96 |
79.28 |
|
Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Interim Results
2024/02 |
Consolidated |
|
- |
- |
|
Non-consolidated |
-14.22 |
- |
|
Results Forecast
2024/08
| Consolidated
| 0.00 |
- |
- |
|
Non-consolidated |
-40.40 |
- |
|
Comment |
■Over allotment(1,365,000) |
Consolidated Subsidiaries |
Name |
Address |
Underwriters |
Allocation |
Underwriter |
Tel |
85% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
5% |
Nomura |
03-3211-1811 |
5% |
Mizuho |
03-5208-3210 |
0.5% |
Akatsuki Securities |
03-5641-7800 |
0.5% |
IwaiCosmo Securities Co.,Ltd. |
06-6229-2890 |
0.5% |
Okasan |
03-3272-2211 |
0.5% |
Kyokuto |
03-3667-9171 |
0.5% |
Toyo |
03-5117-1040 |
0.5% |
Hirota |
06-6201-1181 |
0.5% |
Matsui |
03-5216-0606 |
0.5% |
Marusan |
03-3272-5211 |
0.5% |
Mito |
03-6739-0310 |
0.5% |
Rakuten Securities |
03-6406-2681 |
Major Shareholders |
Shareholder Name |
Ratio |
|
14.71% |
|
12.38% |
|
10.27% |
|
7.86% |
|
7.18% |
|
6.55% |
|
6.19% |
|
6.12% |
|
5.24% |
|
4.14% |
Number of Employees |
21 as of 2024/03/31 |
Birth Date of Representative |
1970/06/25 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX(旧Twitter)でも掲載中。初値予想アンケートも実施中です!
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか?開催希望企業募集中!
|
|